The Joint Commission Honors UPMC Presbyterian Hospital for Innovating Genomic Surveillance in Infection Control
In a significant recognition of innovation in hospital safety, the Joint Commission has awarded UPMC Presbyterian Hospital with the prestigious John M. Eisenberg Local Innovation in Patient Safety and Quality Award. This accolade highlights the hospital's pioneering implementation of bacterial whole genome sequencing (WGS) aimed at detecting infections within hospital settings. Dr. Alex Sundermann, a key figure in this endeavor and a member of the NGD Infection Prevention's Scientific Advisory Board, shared his insights on this breakthrough technology, which promises to revolutionize infection control.
The Joint Commission, an esteemed independent organization responsible for evaluating and accrediting hospitals and other health facilities, emphasizes the vital role of genomic surveillance in contemporary healthcare. The recognition bestowed upon UPMC Presbyterian Hospital underscores the promising operational benefits of WGS in enhancing patient outcomes. The hospital has previously reported that the implementation of this genomic approach not only improved patient safety but also significantly reduced the length of hospital stays and achieved considerable cost savings that surpassed the initial costs of the WGS services.
Dr. Paul Rhodes, founder and CEO of NGD, expressed the importance of this acknowledgment, stating, "This recognition is a powerful and timely acknowledgment by one of the nation's authorities in hospital practice and patient safety." He emphasized that the advanced use of prospective WGS enables infection prevention and control (IPC) teams to identify transmission events effectively, rather than merely confirming past incidences. This capability allows for timely interventions, significantly reducing the risk of further infections in healthcare settings.
The use of WGS goes beyond conventional infection prevention methods, offering hospitals a proactive approach to tackle hidden outbreaks. Multiple studies have indicated that whole-genome sequencing can unveil hospital-based transmission events that would otherwise remain undetected through traditional surveillance methods. The expanding evidence base advocating for routine genomic surveillance emphasizes the urgency to shift from retrospective investigations to a more forward-looking strategy. Dr. Rhodes noted, "This growing body of evidence reinforces the importance of moving beyond retrospective outbreak investigation toward routine, prospective genomic surveillance."
NGD’s state-of-the-art NGD200 system exemplifies cutting-edge technology aimed at transforming infection prevention. This highly automated system performs sample preparation efficiently and at a low cost. Its bioinformatics solution conducts quality control, analysis, and transmission detection without requiring specialized technicians. With the ability to process 48 samples overnight, NGD200's operational efficiency makes it suitable for hospitals of various sizes. Additionally, the system is equipped with EpiAssist, an automated tool that aids in determining potential root causes for infections, allowing IPC teams to focus on validation and intervention processes.
The overall goal of NGD Infection Prevention is to provide hospitals with a comprehensive solution that empowers them to detect and prevent the transmission of infections in real time. By prioritizing genomic surveillance and automation, NGD aims to revolutionize the way hospitals manage patient safety, ultimately leading to improved health outcomes and reduced healthcare costs. As the landscape of healthcare continues to evolve, the implications of such innovations are immense, fostering a future where hospitals can operate more safely and effectively.
About UPMC Presbyterian Hospital: UPMC Presbyterian Hospital is a leading healthcare facility dedicated to excellence in patient care and innovative practices. Its commitment to safety and quality has garnered national recognition. With a focus on integrating advanced technologies like genomic sequencing, the hospital continuously strives to enhance the quality of care it provides to its patients.
About Next Gen Diagnostics (NGD): NGD Infection Prevention specializes in automated whole-genome sequencing solutions designed to assist hospitals in real-time infection detection and prevention. The NGD200 platform processes samples efficiently and with minimal manual intervention, while the accompanying bioinformatics tools streamline analysis and reporting. Located in Cambridge, Massachusetts, NGD aims to lead the charge in implementing effective infection control strategies in healthcare environments.
The Joint Commission, an esteemed independent organization responsible for evaluating and accrediting hospitals and other health facilities, emphasizes the vital role of genomic surveillance in contemporary healthcare. The recognition bestowed upon UPMC Presbyterian Hospital underscores the promising operational benefits of WGS in enhancing patient outcomes. The hospital has previously reported that the implementation of this genomic approach not only improved patient safety but also significantly reduced the length of hospital stays and achieved considerable cost savings that surpassed the initial costs of the WGS services.
Dr. Paul Rhodes, founder and CEO of NGD, expressed the importance of this acknowledgment, stating, "This recognition is a powerful and timely acknowledgment by one of the nation's authorities in hospital practice and patient safety." He emphasized that the advanced use of prospective WGS enables infection prevention and control (IPC) teams to identify transmission events effectively, rather than merely confirming past incidences. This capability allows for timely interventions, significantly reducing the risk of further infections in healthcare settings.
The use of WGS goes beyond conventional infection prevention methods, offering hospitals a proactive approach to tackle hidden outbreaks. Multiple studies have indicated that whole-genome sequencing can unveil hospital-based transmission events that would otherwise remain undetected through traditional surveillance methods. The expanding evidence base advocating for routine genomic surveillance emphasizes the urgency to shift from retrospective investigations to a more forward-looking strategy. Dr. Rhodes noted, "This growing body of evidence reinforces the importance of moving beyond retrospective outbreak investigation toward routine, prospective genomic surveillance."
NGD’s state-of-the-art NGD200 system exemplifies cutting-edge technology aimed at transforming infection prevention. This highly automated system performs sample preparation efficiently and at a low cost. Its bioinformatics solution conducts quality control, analysis, and transmission detection without requiring specialized technicians. With the ability to process 48 samples overnight, NGD200's operational efficiency makes it suitable for hospitals of various sizes. Additionally, the system is equipped with EpiAssist, an automated tool that aids in determining potential root causes for infections, allowing IPC teams to focus on validation and intervention processes.
The overall goal of NGD Infection Prevention is to provide hospitals with a comprehensive solution that empowers them to detect and prevent the transmission of infections in real time. By prioritizing genomic surveillance and automation, NGD aims to revolutionize the way hospitals manage patient safety, ultimately leading to improved health outcomes and reduced healthcare costs. As the landscape of healthcare continues to evolve, the implications of such innovations are immense, fostering a future where hospitals can operate more safely and effectively.
About UPMC Presbyterian Hospital: UPMC Presbyterian Hospital is a leading healthcare facility dedicated to excellence in patient care and innovative practices. Its commitment to safety and quality has garnered national recognition. With a focus on integrating advanced technologies like genomic sequencing, the hospital continuously strives to enhance the quality of care it provides to its patients.
About Next Gen Diagnostics (NGD): NGD Infection Prevention specializes in automated whole-genome sequencing solutions designed to assist hospitals in real-time infection detection and prevention. The NGD200 platform processes samples efficiently and with minimal manual intervention, while the accompanying bioinformatics tools streamline analysis and reporting. Located in Cambridge, Massachusetts, NGD aims to lead the charge in implementing effective infection control strategies in healthcare environments.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.